Pasar al contenido principal

APLICACIONES DE LOS PPRHS CONTRA DIANAS NO MEDICABLES, LNCRNAS Y PCSK9. VEHICULIZACION CON LIPOSOMAS, MODIFICADORES DE DNA Y VECTORES VIRALES. BIOSENSORES PARA DETECCION VIRAL

PID2021-122271OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection

  • Ciudad, Carlos J.|||0000-0002-7855-392X
  • Valiuska, Simonas
  • Rojas, José Manuel
  • Nogales-Altozano, Pablo
  • Aviñó, Ana|||0000-0003-3047-738X
  • Eritja, Ramon|||0000-0001-5383-9334
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
  • Sevilla, Noemí
  • Noé, Verónique
Although the COVID-19 pandemic was declared no longer a global emergency by the World Health Organization in May 2023, SARS-CoV-2 is still infecting people across the world. Many therapeutic oligonucleotides such as ASOs, siRNAs, or CRISPR-based systems emerged as promising antiviral strategies for the treatment of SARS-CoV-2. In this work, we explored the inhibitory potential on SARS-CoV-2 replication of Polypurine Reverse Hoogsteen Hairpins (PPRHs), CC1-PPRH, and CC3-PPRH, targeting specific polypyrimidine sequences within the replicase and Spike regions, respectively, and previously validated for COVID-19 diagnosis. Both PPRHs are bound to their target sequences in the viral genome with high affinity in the order of nM. In vitro, both PPRHs reduced viral replication by more than 92% when transfected into VERO-E6 cells 24 h prior to infection with SARS-CoV-2. In vivo intranasal administration of CC1-PPRH in K18-hACE2 mice expressing the human ACE receptor protected all the animals from SARS-CoV-2 infection. The properties of PPRHs position them as promising candidates for the development of novel therapeutics against SARS-CoV-2 and other viral infections.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Detection of SARS-CoV-2 virus by triplex enhanced nucleic acid detection assay (TENADA)

  • Aviñó, Anna
  • Cuestas-Ayllón, Carlos
  • Gutiérrez-Capitán, Manuel
  • Vilaplana, L.
  • Grazú, Valeria
  • Noé, Véronique
  • Balada, Eva
  • Baldi Coll, Antonio
  • Félix, Alex J.
  • Aubets, Eva
  • Valiuska, Simonas
  • Domínguez, Arnau
  • Gargallo, Raimundo
  • Eritja Casadellà, Ramón
  • Marco, María Pilar
  • Fernández Sánchez, César
  • Fuente, Jesús M. de la
  • Ciudad, Carlos J.
This article belongs to the Special Issue Chemistry and Biology of Noncanonical Nucleic Acid Structures: From Physicochemical Properties to Therapeutic Applications., SARS-CoV-2, a positive-strand RNA virus has caused devastating effects. The standard method for COVID diagnosis is based on polymerase chain reaction (PCR). The method needs expensive reagents and equipment and well-trained personnel and takes a few hours to be completed. The search for faster solutions has led to the development of immunological assays based on antibodies that recognize the viral proteins that are faster and do not require any special equipment. Here, we explore an innovative analytical approach based on the sandwich oligonucleotide hybridization which can be adapted to several biosensing devices including thermal lateral flow and electrochemical devices, as well as fluorescent microarrays. Polypurine reverse-Hoogsteen hairpins (PPRHs) oligonucleotides that form high-affinity triplexes with the polypyrimidine target sequences are used for the efficient capture of the viral genome. Then, a second labeled oligonucleotide is used to detect the formation of a trimolecular complex in a similar way to antigen tests. The reached limit of detection is around 0.01 nM (a few femtomoles) without the use of any amplification steps. The triplex enhanced nucleic acid detection assay (TENADA) can be readily adapted for the detection of any pathogen requiring only the knowledge of the pathogen genome sequence., This work was funded by Consejo Superior de Investigaciones Científicas (CSIC) (Project POC4CoV, CSIC-COV19-041), CHEST Foundation (040105-268-A1V), La Marató de TV3 Foundation (Project 202110-30-31-32-33 to R.E., C.C., V.N., V.G., J.M.), Spanish Ministry of Science and Innovation (MICINN) [PID2020-118145RB-I100 to R.E., PID2021-122271OB-I00 to V.N. and C.C.; PID2019-107158GB-I00 to R.G.] DGA and Fondos Feder (Bionanosurf E15_17R) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/0019 to R.E., CB06/01/0036 to P.M., CB16/01/00263 to J.M), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commision, European Regional Development Fund). This research was also funded by the European Commision-NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI). We want to particularly acknowledge the patients and the Biobank of the Aragon Health System (PT20/00112), integrated in the Spanish National Biobanks Network for their collaboration., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biophysical evaluation of antiparallel triplexes for biosensing and biomedical applications

  • Domínguez, Arnau
  • Gargallo, Raimundo
  • Cuestas-Ayllón, Carlos
  • Grazú, Valeria
  • Fàbrega, Carme
  • Valiuska, Simonas
  • Noé, Véronique
  • Ciudad, Carlos J.
  • Calderón, Enrique J.
  • Fuente, Jesús M. de la
  • Eritja Casadellà, Ramón
  • Aviñó, Anna
Polypyrimidine sequences can be targeted by antiparallel clamps forming triplex structures either for biosensing or therapeutic purposes. Despite its successful implementation, their biophysical properties remain to be elusive. In this work, PAGE, circular dichroism and multivariate analysis were used to evaluate the properties of PPRHs directed to SARS-CoV-2 genome. Several PPRHs designed to target various polypyrimidine sites within the viral genome were synthesized. These PPRHs displayed varying binding affinities, influenced by factors such as the length of the PPRH and its GC content. The number and position of pyrimidine interruptions relative to the 4 T loop of the PPRH was found a critical factor, affecting the binding affinity with the corresponding target. Moreover, these factors also showed to affect in the intramolecular and intermolecular equilibria of PPRHs alone and when hybridized to their corresponding targets, highlighting the polymorphic nature of these systems. Finally, the functionality of the PPRHs was evaluated in a thermal lateral flow sensing device showing a good correspondence between their biophysical properties and detection limits. These comprehensive studies contribute to the understanding of the critical factors involved in the design of PPRHs for effective targeting of biologically relevant genomes through the formation of triplex structures under neutral conditions., This work was funded by Fundació la Marató de TV3 (Project 202110-30-31-32-33), Consejo Superior de Investigaciones Científicas (CSIC) (Project POC4CoV, CSIC-COV19-041, 202380E152), Spanish Ministry of Science and Innovation (MICINN) [PID2020-118145RB-I100; PID2021-122271OB-I00; PID2019-107158GB-I00], DGA and Fondos Feder (Bionanosurf E15_17R) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/0019, CB16/01/00263, CB06/02/0014, and Triplex-POCFlu/RSV), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commission, European Regional Development Fund). This research was also funded by the European Commission-NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI). The work done in this study has been supported by the ICTS NANBIOSIS unit U29 Oligonucleotide Synthesis Platform (OSP)., Peer reviewed